On September 8, 2022 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) reported that the company will participate in the H.C. Wainwright Global Investment Conference in New York City on Wednesday, September 14, 2022 (Press release, Vanda Pharmaceuticals, SEP 8, 2022, https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-hc-wainwright-global-investment-conference-301620904.html [SID1234619291]). A corporate presentation is scheduled for 8:30 a.m. Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The corporate presentation given at the H.C. Wainwright Global Investment Conference may be accessed live on Vanda’s corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda’s website for a period of approximately 30 days.